Skip to main content
Premium Trial:

Request an Annual Quote

GATC Signs $3.2M DNA-Sequencing Contract with Medical Research Council

NEW YORK, May 26 (GenomeWeb News) - GATC Biotech today said it has signed a €2.5-million ($3.2 million) DNA-sequencing contract with the Medical Research Council.

According to the contract, GATC will provide the MRC's 35 sites in the United Kingdom with DNA sequencing services over a period of at least three years in return for about €2.5 million.

The MRC said it selected GATC over 10 other potential DNA sequencing service providers. A key selling point for GATC was its "fully automated sequencing process that reduces the level of human intervention and error," GATC said.

The Scan

Looking for Omicron

NPR reports that SARS-CoV-2 testing in the US has gotten better but also that some experts say more needs to be done to better track the Omicron variant.

Holmes Alleges Abuse

The Associated Press reports that Theranos' Elizabeth Holmes has testified at her wire fraud trial that her business and romantic partner abused her.

Bit More Diverse, But More to Do

While Black and Hispanic patients are more likely to participate in cancer clinical trials than previously, they are still underrepresented, according to US News & World Report.

PNAS Papers on Yeast Gene Silencing, Zika Virus Inhibition, Immunoglobulin Hypermutation

In PNAS this week: gene silencing in Saccharomyces cerevisiae, possible neuroprotective role for SHFL in a mouse model of Zika virus infection, and more.